Skip to content

PolitiKit

Andre Albinati's lobbying: the clients they represent and every meeting they've reported since November 2021.

← Lobbying

Consultant lobbyist

Andre Albinati

Earnscliffe Strategy Group

Former public offices

  • Multilateral Trade Policy Advisor to the Minister, Office of the Minister, International Trade (1999–2002)
  • Senior Policy Advisor to the Minister, Office of the Minister, Human Resources Development Canada (1998–1999)
  • Policy Advisor to the Minister, Office of the Minister, Human Resources Development Canada (1996–1998)
  • Policy Advisor to the Minister, Office of the Minister, International Cooperation and Responsible for La Francophonie (1996–1996)
Meetings this Parliament
26
Since Nov 2021
45
Active registrations
15

Reported meetings

  • Eli Lilly Canada Inc.
    • Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Read more

    The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry

    Official report

  • Eli Lilly Canada Inc.
    • Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Read more

    The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry

    Official report

  • Covista inc
    • Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)

    C-15

    Canada Student Financial Assistance Read more

    The Budget 2025 Implementation Act, No. 1 (Bill C-15), Changes to Canada Student Financial Assistance

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Seeking continued funding from the federal government for the CFS+ national digital inclusion program.

    Official report

  • Covista inc
    • Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
    Canada Student Financial Assistance

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Seeking continued funding from the federal government for the CFS+ national digital inclusion program.

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Advance client's goals to secure funding for research, discovery and commercialization of innovative medical products, build ecosystems to increase research and development capacity in the field of life sciences in Canada. Read more

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Discussing biomanufacturing initiatives in Canada globally as it relates to federal government policy, including with respect to defence uses.

    Official report

  • Cantak Corporation
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

  • Cantak Corporation
    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

  • Cantak Corporation
    • Paul Moen · Chief of Staff to the minister, Innovation, Science and Economic Development Canada (ISED)
    • Soha Samii · Regional Advisor for Western Canada, Innovation, Science and Economic Development Canada (ISED)
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

    • Paul Moen · Chief of Staff to the Minister, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Seeking continued funding from the federal government for the CFS+ national digital inclusion program.

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Advance client's goals to secure funding for research, discovery and commercialization of innovative medical products, build ecosystems to increase research and development capacity in the field of life sciences in Canada. Read more

    Official report

  • Eli Lilly Canada Inc.
    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry Read more

    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.

    Free trade treaty agreement as it relates to the Canada/US Free Trade Agreement and free trade negotiations as it relates to Columbia, India, and the European Union.

    Official report

  • Cantak Corporation
    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Discussing biomanufacturing initiatives in Canada globally as it relates to federal government policy, including with respect to defence uses.

    Official report

  • Eli Lilly Canada Inc.
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Read more

    The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry

    Free trade treaty agreement as it relates to the Canada/US Free Trade Agreement and free trade negotiations as it relates to Columbia, India, and the European Union.

    Official report

  • Cantak Corporation
    • Niloo Boroun · Director of International Policy, Finance Canada (FIN)
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

  • Cantak Corporation
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

  • Cantak Corporation
    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    Engage federal authorities on tariff rate quotas for steel derivative products, including classification of certain products, to ensure business continuity and reliability of affordable supply of goods for Canadian private sector operators. Read more

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Advance client's goals to secure funding for research, discovery and commercialization of innovative medical products, build ecosystems to increase research and development capacity in the field of life sciences in Canada. Read more

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Advance client's goals to secure funding for research, discovery and commercialization of innovative medical products, build ecosystems to increase research and development capacity in the field of life sciences in Canada. Read more

    Official report

  • Eli Lilly Canada Inc.
    • Niloo Boroun · Director of International Policy, Finance Canada (FIN)
    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Read more

    Free trade treaty agreement as it relates to the Canada/US Free Trade Agreement and free trade negotiations as it relates to Columbia, India, and the European Union.

    Official report

  • Eli Lilly Canada Inc.
    • Brandan Rowe · Chief of Staff, Privy Council Office (PCO)
    • Miro Froehlich · Director of Policy, Privy Council Office (PCO)
    Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.

    Official report

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    To update and discuss current Strategic Innovation Fund (SIF) funding as well as biomanufacturing initiatives in Canada and globally.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.